LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma
- PMID: 33431817
- PMCID: PMC7801696
- DOI: 10.1038/s41419-020-03302-2
LncRNA linc00312 suppresses radiotherapy resistance by targeting DNA-PKcs and impairing DNA damage repair in nasopharyngeal carcinoma
Abstract
Radioresistance is the main obstacle in the clinical management of nasopharyngeal carcinoma (NPC). linc00312 is deregulated in a number of human cancers, including NPC. However, the detailed functions and underlying mechanisms of linc00312 in regulating radiosensitivity of NPC remains unknown. In this study, cox regression analysis was used to assess the association between linc00312 and NPC patients' survival after radiotherapy. Our results reveal that linc00312 is significantly down-regulated in NPC tissues and patients with higher expression of linc00312 are significantly associated with longer overall survival and better short-term radiotherapy efficacy. Overexpression of linc00312 could increase the sensitivity of NPC cells to ionizing radiation, as indicated by clonogenic survival assay, comet assay, and flow cytometry. Mechanistically, RNA pull down and RNA immunoprecipitation were performed to investigate the binding proteins of linc00312. linc00312 directly binds to DNA-PKcs, hinders the recruitment of DNA-PKcs to Ku80, and inhibits phosphorylation of AKT-DNA-PKcs axis, therefore inhibiting the DNA damage signal sensation and transduction in the NHEJ repair pathway. In addition, linc00312 impairs DNA repair and cell cycle control by suppressing MRN-ATM-CHK2 signal and ATR-CHK1 signal. In summary, we identified DNA-PKcs as the binding protein of linc00312 and revealed a novel mechanism of linc00312 in the DNA damage response, providing evidence for a potential therapeutic strategy in NPC.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures






Similar articles
-
CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.Biomed Pharmacother. 2020 Mar;123:109748. doi: 10.1016/j.biopha.2019.109748. Epub 2019 Dec 20. Biomed Pharmacother. 2020. PMID: 31869663
-
Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma.J Mol Histol. 2013 Oct;44(5):545-54. doi: 10.1007/s10735-013-9503-x. Epub 2013 Mar 26. J Mol Histol. 2013. PMID: 23529758
-
LINC-PINT impedes DNA repair and enhances radiotherapeutic response by targeting DNA-PKcs in nasopharyngeal cancer.Cell Death Dis. 2021 May 7;12(5):454. doi: 10.1038/s41419-021-03728-2. Cell Death Dis. 2021. PMID: 33963177 Free PMC article.
-
Radio-Susceptibility of Nasopharyngeal Carcinoma: Focus on Epstein- Barr Virus, MicroRNAs, Long Non-Coding RNAs and Circular RNAs.Curr Mol Pharmacol. 2020;13(3):192-205. doi: 10.2174/1874467213666191227104646. Curr Mol Pharmacol. 2020. PMID: 31880267 Review.
-
The exciting encounter between lncRNAs and radiosensitivity in IR-induced DNA damage events.Mol Biol Rep. 2023 Feb;50(2):1829-1843. doi: 10.1007/s11033-022-07966-1. Epub 2022 Dec 12. Mol Biol Rep. 2023. PMID: 36507968 Review.
Cited by
-
Development and validation of a novel lysosome-related LncRNA signature for predicting prognosis and the immune landscape features in colon cancer.Sci Rep. 2024 Jan 5;14(1):622. doi: 10.1038/s41598-023-51126-9. Sci Rep. 2024. PMID: 38182713 Free PMC article.
-
The DNA damage repair-related lncRNAs signature predicts the prognosis and immunotherapy response in gastric cancer.Front Immunol. 2023 Jun 29;14:1117255. doi: 10.3389/fimmu.2023.1117255. eCollection 2023. Front Immunol. 2023. PMID: 37457685 Free PMC article.
-
ATR-binding lncRNA ScaRNA2 promotes cancer resistance through facilitating efficient DNA end resection during homologous recombination repair.J Exp Clin Cancer Res. 2023 Sep 30;42(1):256. doi: 10.1186/s13046-023-02829-4. J Exp Clin Cancer Res. 2023. PMID: 37775817 Free PMC article.
-
Enhancement of the Tumor Suppression Effect of High-dose Radiation by Low-dose Pre-radiation Through Inhibition of DNA Damage Repair and Increased Pyroptosis.Dose Response. 2024 Apr 11;22(2):15593258241245804. doi: 10.1177/15593258241245804. eCollection 2024 Apr-Jun. Dose Response. 2024. PMID: 38617388 Free PMC article.
-
Radioresistance and brain metastases: a review of the literature and applied perspective.Front Oncol. 2024 Oct 30;14:1477448. doi: 10.3389/fonc.2024.1477448. eCollection 2024. Front Oncol. 2024. PMID: 39540151 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous